call Toll Free (US/Canada): +1 866 658 6826 | call+1 425 320 4776 | call (UK): +44 1865 60 0662 | call (Ind): +91 9096278110 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Adrenocorticotropic Hormone Market
Inquire Before Buying Request for Sample

Adrenocorticotropic Hormone Market

Home Healthcare And Pharmaceutical Adrenocorticotropic Hormone Market

Adrenocorticotropic Hormone (ACTH) Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Source (Natural, Synthetic): By Indication (Rheumatology, Neurology, Nephrotic Syndrome, Ophthalmology); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: April 2023
  • Report ID: BWC23315
  • Available Format: PDF
  • Page: 400

Report Overview

Increasing prevalence of disorders related to the adrenal gland and growing geriatric population worldwide are projected to propel the expansion of global adrenocorticotropic hormone market during the forecast period between 2023 and 2029.

Global Adrenocorticotropic Hormone (ACTH) Market - Industry Trends & Forecast Report, 2029

Global adrenocorticotropic hormone (ACTH) market size was estimated at USD 1.39 billion in 2022. During the forecast period between 2023 and 2029, the size of global adrenocorticotropic hormone market is projected to grow at CAGR of 6.48% reaching a value of USD 2.14 billion by 2029. Major growth drivers for global adrenocorticotropic hormone market include increasing incidence of adrenal insufficiency and autoimmune diseases, growing awareness about the benefits of early diagnosis and treatment, and the availability of advanced diagnostic techniques. The increasing incidence of autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis, and lupus is a major driver of the ACTH market. These conditions require long-term management, and ACTH is used as a treatment option to manage symptoms. The availability of advanced diagnostic techniques such as immunoassays, radioimmunoassay, and ELISA has increased the demand for ACTH testing. These techniques help in the early diagnosis of adrenal insufficiency, which is a major factor driving the growth of the ACTH market. Also, biologics have gained popularity in the treatment of autoimmune and inflammatory diseases due to their high specificity and low toxicity. ACTH is a biologic hormone that is used to treat these conditions, and the increasing adoption of biologics is expected to boost the growth of the ACTH market.

Adrenocorticotropic Hormone Market

Global Adrenocorticotropic Hormone Market – Overview

Adrenocorticotropic hormone (ACTH) is a hormone produced by the pituitary gland that stimulates the production and release of cortisol from the adrenal glands. Cortisol is a steroid hormone that is important in regulating various bodily functions such as metabolism, immune response, and stress response. ACTH is primarily used in the diagnosis of adrenal insufficiency and as a treatment for certain autoimmune and inflammatory conditions such as multiple sclerosis and rheumatoid arthritis. The market is driven by factors such as the increasing prevalence of autoimmune and inflammatory diseases, growing demand for advanced diagnostic techniques, and increasing adoption of biologics. The global ACTH market is expected to continue to grow in the coming years, although challenges such as the high cost of therapy and potential adverse effects associated with prolonged use may pose challenges to the growth of the market.

Global Adrenocorticotropic Hormone Market

Growth Drivers

Growing Geriatric Population Worldwide

The rising geriatric population worldwide is expected to have a positive impact on the global adrenocorticotropic hormone (ACTH) market. As people age, the risk of developing adrenal insufficiency and other conditions that require ACTH therapy increases. The geriatric population is also more likely to suffer from autoimmune and inflammatory diseases, which are major indications for ACTH therapy. Furthermore, the geriatric population is expected to increase significantly in the coming years. According to the World Health Organization, the population of individuals aged 60 years and above exceeded the number of children below 5 years old in 2020. This demographic shift is expected to increase the demand for healthcare services and products, including ACTH therapy. In addition, the geriatric population tends to have a higher prevalence of chronic diseases, which require long-term management. This is expected to boost the demand for ACTH therapy, which is used to manage symptoms associated with chronic conditions such as multiple sclerosis and rheumatoid arthritis.

Restraints

High Cost of Treatment

The high cost of treatment is expected to hinder the growth of the global adrenocorticotropic hormone (ACTH) market. ACTH therapy is a relatively expensive treatment option, which may pose a challenge for patients who require long-term treatment. This high cost can limit patient access to ACTH therapy and may lead to the adoption of alternative treatments. In addition, healthcare systems and insurance companies may be reluctant to cover the cost of ACTH therapy due to its high cost. This can further limit patient access to the treatment and may negatively impact the growth of the ACTH market. Moreover, prolonged use of ACTH therapy may lead to potential adverse effects such as hypertension, osteoporosis, and diabetes. These risks may discourage patients and healthcare providers from choosing ACTH therapy, which can also impact the growth of the market.

Impact of COVID-19 on Global Adrenocorticotropic Hormone Market

COVID-19 had a dual impact on the global adrenocorticotropic hormone (ACTH) market. The pandemic led to disruptions in supply chains, decreased patient visits to healthcare facilities, and delays in clinical trials, all of which impacted the ACTH market. On the one hand, the pandemic led to an increased demand for ACTH therapy in the treatment of severe COVID-19 cases. ACTH therapy has been used as an adjunctive treatment for COVID-19 patients who require mechanical ventilation and are at risk of developing acute respiratory distress syndrome (ARDS). This has led to an increased demand for ACTH products in certain regions. On the other hand, the pandemic led to a decrease in non-COVID-19-related ACTH therapy due to the decreased patient visits to healthcare facilities. The lockdowns and travel restrictions also disrupted the global supply chain, which have impacted the availability of ACTH products. Also, delays in clinical trials due to the pandemic impacted the development of new ACTH products and may delay the approval of new treatments.

Global Adrenocorticotropic Hormone Market

Segmental Coverage

Global Adrenocorticotropic Hormone Market – By Source

By source, the global adrenocorticotropic hormone market is bifurcated into Natural and Synthetic segments.

Global Adrenocorticotropic Hormone Market – By Indication

By indication, the global adrenocorticotropic hormone market is divided into Rheumatology, Neurology, Nephrotic Syndrome, and Ophthalmology segments. The rheumatology segment holds the highest market share due to prevalence of arthritis, which is a chronic autoimmune disease that causes inflammation, stiffness, and swelling in the joints, particularly in the lower extremities. Arthritis encompasses approximately 100 types of joint diseases, including osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and gout. Additionally, patients with psoriasis also develop arthritis, contributing to the growth of the rheumatology segment.

Global Adrenocorticotropic Hormone Market – By Distribution Channel

Based on distribution channel, the global adrenocorticotropic hormone market is divided into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. Online pharmacies are the dominant segment in the global Adrenocorticotropic Hormone (ACTH) market because they offer the convenience of ordering medication from home, eliminating the need to visit a pharmacy. The online pharmacies have a wider reach compared to traditional pharmacies, catering to customers from various locations, including remote areas. Also, they are cost-effective, often offering lower prices for medication and frequently providing discounts and other promotional offers. The increasing adoption of e-commerce globally has contributed to the popularity of online pharmacies, as people become more comfortable with buying products online.

Global Adrenocorticotropic Hormone Market – By Region

The in-depth research report covers adrenocorticotropic hormone markets in various major countries across five key regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America region holds the highest market share in the global adrenocorticotropic Hormone (ACTH) market due to a high prevalence of ACTH-related disorders, advanced healthcare infrastructure, and favorable reimbursement policies. Similarly, Europe holds the second-highest market share due to an increasing prevalence of ACTH-related disorders, a well-established healthcare infrastructure, and government initiatives to improve access to treatment. The high prevalence of ACTH-related disorders in both regions has contributed to the growth of the ACTH market. The well-developed healthcare infrastructure and government initiatives have also made ACTH treatment more accessible to patients in these regions.

Competitive Landscape

Major players operating in global adrenocorticotropic hormone market include Novartis International AG, Pfizer Inc., Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals PLC, West-Ward Pharmaceuticals Corp., Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Ferring Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Amphastar Pharmaceuticals, Inc., EMD Serono, Inc., Mylan N.V., and Taj Pharmaceuticals Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period– 2023–2029

Facts Covered

Revenue in USD Billion

Market Coverage

North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)

Product/ Service Segmentation

Source, Indication, Distribution Channel, Region

Key Players

Novartis International AG, Pfizer Inc., Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals PLC, West-Ward Pharmaceuticals Corp., Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Ferring Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Amphastar Pharmaceuticals, Inc., EMD Serono, Inc., Mylan N.V., Taj Pharmaceuticals Ltd

 

By Source

  • Natural

  • Synthetic

By Indication

  • Rheumatology

  • Neurology

  • Nephrotic Syndrome

  • Ophthalmology

By Distribution Channel

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Adrenocorticotropic Hormone (ACTH) Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. The increasing prevalence of disorders related to the adrenal gland
        2. Rising geriatric population worldwide
      2. Restraints
        1. Excessive cost of treatment
        2. Side effects associated with ACTH therapy
      3. Opportunities
        1. The development of novel therapies
        2. Increasing demand for personalized medicine
      4. Challenges
        1.  Stringent regulatory requirements and the increasing competition from alternative therapies.
    3. Technology Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Adrenocorticotropic Hormone (ACTH) Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share and Forecast
      1. By Source
        1. Natural
        2. Synthetic
      2. By Indication
        1. Rheumatology
        2. Neurology
        3. Nephrotic Syndrome
        4. Ophthalmology
        5. Others
      3. By Distribution Channel
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Adrenocorticotropic Hormone (ACTH) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Source
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. United States
          1. By Source
          2. By Indication
          3. By Distribution Channel
        2. Canada
          1. By Source
          2. By Indication
          3. By Distribution Channel
  6. Europe Adrenocorticotropic Hormone (ACTH) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Source
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. Germany
          1. By Source
          2. By Indication
          3. By Distribution Channel
        2. United Kingdom
          1. By Source
          2. By Indication
          3. By Distribution Channel
        3. Italy
          1. By Source
          2. By Indication
          3. By Distribution Channel
        4. France
          1. By Source
          2. By Indication
          3. By Distribution Channel
        5. Spain
          1. By Source
          2. By Indication
          3. By Distribution Channel
        6. Belgium
          1. By Source
          2. By Indication
          3. By Distribution Channel
        7. Russia
          1. By Source
          2. By Indication
          3. By Distribution Channel
        8. The Netherlands
          1. By Source
          2. By Indication
          3. By Distribution Channel
        9. Rest of Europe
          1. By Source
          2. By Indication
          3. By Distribution Channel
  7. Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Source
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. China
          1. By Source
          2. By Indication
          3. By Distribution Channel
        2. India
          1. By Source
          2. By Indication
          3. By Distribution Channel
        3. Japan
          1. By Source
          2. By Indication
          3. By Distribution Channel
        4. South Korea
          1. By Source
          2. By Indication
          3. By Distribution Channel
        5. Australia & New Zealand
          1. By Source
          2. By Indication
          3. By Distribution Channel
        6. Indonesia
          1. By Source
          2. By Indication
          3. By Distribution Channel
        7. Malaysia
          1. By Source
          2. By Indication
          3. By Distribution Channel
        8. Singapore
          1. By Source
          2. By Indication
          3. By Distribution Channel
        9. Vietnam
          1. By Source
          2. By Indication
          3. By Distribution Channel
        10. Rest of APAC
          1. By Source
          2. By Indication
          3. By Distribution Channel
  8. Latin America Adrenocorticotropic Hormone (ACTH) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Source
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. Brazil
          1. By Source
          2. By Indication
          3. By Distribution Channel
        2. Mexico
          1. By Source
          2. By Indication
          3. By Distribution Channel
        3. Argentina
          1. By Source
          2. By Indication
          3. By Distribution Channel
        4. Peru
          1. By Source
          2. By Indication
          3. By Distribution Channel
        5. Rest of LATAM
          1. By Source
          2. By Indication
          3. By Distribution Channel
  9. Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Source
      2. By Indication
      3. By Distribution Channel
      4. By Country
        1. Saudi Arabia
          1. By Source
          2. By Indication
          3. By Distribution Channel
        2. UAE
          1. By Source
          2. By Indication
          3. By Distribution Channel
        3. Qatar
          1. By Source
          2. By Indication
          3. By Distribution Channel
        4. Kuwait
          1. By Source
          2. By Indication
          3. By Distribution Channel
        5. South Africa
          1. By Source
          2. By Indication
          3. By Distribution Channel
        6. Nigeria
          1. By Source
          2. By Indication
          3. By Distribution Channel
        7. Algeria
          1. By Source
          2. By Indication
          3. By Distribution Channel
        8. Rest of MEA
          1. By Source
          2. By Indication
          3. By Distribution Channel
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Adrenocorticotropic Hormone (ACTH) Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Adrenocorticotropic Hormone (ACTH) Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Novartis International AG
    2. Pfizer Inc.
    3. Mallinckrodt Pharmaceuticals
    4. Hikma Pharmaceuticals PLC
    5. West-Ward Pharmaceuticals Corp.
    6. Horizon Therapeutics plc
    7. Sun Pharmaceutical Industries Ltd.
    8. Merck & Co., Inc.
    9. Ferring Pharmaceuticals
    10. Teva Pharmaceutical Industries Ltd.
    11. Aspen Pharmacare Holdings Limited
    12. Amphastar Pharmaceuticals, Inc.
    13. EMD Serono, Inc.
    14. Mylan N.V.
    15. Taj Pharmaceuticals Ltd.
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1       Global Adrenocorticotropic Hormone (ACTH) Segmentation

Figure 2       Global Adrenocorticotropic Hormone (ACTH) Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 5       Global Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 6       Global Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 7       Global Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 8       Global Adrenocorticotropic Hormone (ACTH) Market Share, By Region, By Value, 2019–2029

Figure 9       North America Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 10     North America Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 11     North America Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 12     North America Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 13     North America Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Figure 14     United States Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 15     United States Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 16     United States Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 17     United States Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 18     Canada Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 19     Canada Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 20     Canada Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 21     Canada Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 22     Europe Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 23     Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 24     Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 25     Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 26     Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Figure 27     Germany Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 28     Germany Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 29     Germany Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 30     Germany Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 31     United Kingdom Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 32     United Kingdom Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 33     United Kingdom Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 34     United Kingdom Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 35     Italy Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 36     Italy Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 37     Italy Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 38     Italy Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 39     France Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 40     France Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 41     France Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 42     France Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 43     Spain Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 44     Spain Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 45     Spain Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 46     Spain Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 47     Belgium Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 48     Belgium Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 49     Belgium Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 50     Belgium Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 51     Russia Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 52     Russia Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 53     Russia Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 54     Russia Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 55     The Netherlands Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 56     The Netherlands Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 57     The Netherlands Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 58     The Netherlands Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 59     Rest of Europe Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 60     Rest of Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 61     Rest of Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 62     Rest of Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 63     Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 64     Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 65     Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 66     Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 67     Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Figure 68     China Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 69     China Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 70     China Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 71     China Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 72     India Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 73     India Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 74     India Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 75     India Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 76     Japan Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 77     Japan Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 78     Japan Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 79     Japan Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 80     South Korea Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 81     South Korea Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 82     South Korea Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 83     South Korea Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 84     Australia & New Zealand Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 85     Australia & New Zealand Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 86     Australia & New Zealand Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 87     Australia & New Zealand Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 88     Indonesia Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 89     Indonesia Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 90     Indonesia Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 91     Indonesia Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 92     Malaysia Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 93     Malaysia Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 94     Malaysia Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 95     Malaysia Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 96     Singapore Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 97     Singapore Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 98     Singapore Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 99     Singapore Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 100   Vietnam Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 101   Vietnam Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 102   Vietnam Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 103   Vietnam Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 104   Rest of APAC Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 105   Rest of APAC Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 106   Rest of APAC Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 107   Rest of APAC Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 108   Latin America Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 109   Latin America Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 110   Latin America Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 111   Latin America Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 112   Latin America Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Figure 113   Brazil Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 114   Brazil Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 115   Brazil Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 116   Brazil Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 117   Mexico Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 118   Mexico Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 119   Mexico Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 120   Mexico Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 121   Argentina Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 122   Argentina Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 123   Argentina Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 124   Argentina Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 125   Peru Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 126   Peru Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 127   Peru Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 128   Peru Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 129   Rest of LATAM Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 130   Rest of LATAM Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 131   Rest of LATAM Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 132   Rest of LATAM Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 133   Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 134   Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 135   Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 136   Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 137   Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Figure 138   Saudi Arabia Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 139   Saudi Arabia Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 140   Saudi Arabia Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 141   Saudi Arabia Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 142   UAE Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 143   UAE Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 144   UAE Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 145   UAE Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 146   Qatar Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 147   Qatar Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 148   Qatar Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 149   Qatar Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 150   Kuwait Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 151   Kuwait Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 152   Kuwait Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 153   Kuwait Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 154   South Africa Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 155   South Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 156   South Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 157   South Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 158   Nigeria Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 159   Nigeria Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 160   Nigeria Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 161   Nigeria Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 162   Algeria Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 163   Algeria Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 164   Algeria Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 165   Algeria Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 166   Rest of MEA Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Figure 167   Rest of MEA Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Figure 168   Rest of MEA Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Figure 169   Rest of MEA Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

List of Tables

Table 1 Global Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 2 Global Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 3 Global Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 4 Global Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 5 Global Adrenocorticotropic Hormone (ACTH) Market Share, By Region, By Value, 2019–2029

Table 6 North America Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 7 North America Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 8 North America Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 9 North America Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 10      North America Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Table 11      United States Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 12      United States Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 13      United States Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 14      United States Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 15      Canada Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 16      Canada Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 17      Canada Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 18      Canada Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 19      Europe Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 20      Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 21      Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 22      Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 23      Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Table 24      Germany Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 25      Germany Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 26      Germany Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 27      Germany Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 28      United Kingdom Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 29      United Kingdom Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 30      United Kingdom Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 31      United Kingdom Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 32      Italy Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 33      Italy Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 34      Italy Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 35      Italy Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 36      France Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 37      France Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 38      France Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 39      France Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 40      Spain Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 41      Spain Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 42      Spain Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 43      Spain Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 44      Belgium Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 45      Belgium Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 46      Belgium Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 47      Belgium Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 48      Russia Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 49      Russia Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 50      Russia Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 51      Russia Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 52      The Netherlands Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 53      The Netherlands Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 54      The Netherlands Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 55      The Netherlands Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 56      Rest of Europe Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 57      Rest of Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 58      Rest of Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 59      Rest of Europe Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 60      Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 61      Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 62      Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 63      Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 64      Asia-Pacific Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Table 65      China Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 66      China Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 67      China Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 68      China Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 69      India Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 70      India Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 71      India Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 72      India Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 73      Japan Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 74      Japan Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 75      Japan Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 76      Japan Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 77      South Korea Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 78      South Korea Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 79      South Korea Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 80      South Korea Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 81      Australia & New Zealand Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 82      Australia & New Zealand Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 83      Australia & New Zealand Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 84      Australia & New Zealand Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 85      Indonesia Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 86      Indonesia Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 87      Indonesia Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 88      Indonesia Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 89      Malaysia Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 90      Malaysia Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 91      Malaysia Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 92      Malaysia Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 93      Singapore Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 94      Singapore Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 95      Singapore Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 96      Singapore Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 97      Vietnam Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 98      Vietnam Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 99      Vietnam Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 100    Vietnam Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 101    Rest of APAC Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 102    Rest of APAC Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 103    Rest of APAC Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 104    Rest of APAC Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 105    Latin America Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 106    Latin America Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 107    Latin America Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 108    Latin America Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 109    Latin America Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Table 110    Brazil Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 111    Brazil Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 112    Brazil Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 113    Brazil Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 114    Mexico Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 115    Mexico Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 116    Mexico Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 117    Mexico Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 118    Argentina Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 119    Argentina Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 120    Argentina Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 121    Argentina Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 122    Peru Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 123    Peru Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 124    Peru Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 125    Peru Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 126    Rest of LATAM Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 127    Rest of LATAM Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 128    Rest of LATAM Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 129    Rest of LATAM Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 130    Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 131    Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 132    Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 133    Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 134    Middle East & Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Country, By Value, 2019–2029

Table 135    Saudi Arabia Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 136    Saudi Arabia Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 137    Saudi Arabia Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 138    Saudi Arabia Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 139    UAE Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 140    UAE Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 141    UAE Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 142    UAE Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 143    Qatar Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 144    Qatar Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 145    Qatar Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 146    Qatar Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 147    Kuwait Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 148    Kuwait Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 149    Kuwait Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 150    Kuwait Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 151    South Africa Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 152    South Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 153    South Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 154    South Africa Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 155    Nigeria Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 156    Nigeria Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 157    Nigeria Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 158    Nigeria Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 159    Algeria Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 160    Algeria Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 161    Algeria Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 162    Algeria Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 163    Rest of MEA Adrenocorticotropic Hormone (ACTH) Market Size, By Value (USD Million), 2019–2029

Table 164    Rest of MEA Adrenocorticotropic Hormone (ACTH) Market Share, By Source, By Value, 2019–2029

Table 165    Rest of MEA Adrenocorticotropic Hormone (ACTH) Market Share, By Indication, By Value, 2019–2029

Table 166    Rest of MEA Adrenocorticotropic Hormone (ACTH) Market Share, By Distribution Channel, By Value, 2019–2029

Table 167    Novartis International AG Company Overview

Table 168    Novartis International AG Financial Overview

Table 169    Pfizer Inc. Company Overview

Table 170    Pfizer Inc. Financial Overview

Table 171    Mallinckrodt Pharmaceuticals Company Overview

Table 172    Mallinckrodt Pharmaceuticals Financial Overview

Table 173    Hikma Pharmaceuticals PLC Company Overview

Table 174    Hikma Pharmaceuticals PLC Financial Overview

Table 175    West-Ward Pharmaceuticals Corp. Company Overview

Table 176    West-Ward Pharmaceuticals Corp. Financial Overview

Table 177    Horizon Therapeutics plc Company Overview

Table 178    Horizon Therapeutics plc Financial Overview

Table 179    Sun Pharmaceutical Industries Ltd. Company Overview

Table 180    Sun Pharmaceutical Industries Ltd. Financial Overview

Table 181    Merck & Co., Inc. Company Overview

Table 182    Merck & Co., Inc. Financial Overview

Table 183    Ferring Pharmaceuticals Company Overview

Table 184    Ferring Pharmaceuticals Financial Overview

Table 185    Teva Pharmaceutical Industries Ltd. Company Overview

Table 186    Teva Pharmaceutical Industries Ltd. Financial Overview

Table 187    Aspen Pharmacare Holdings Limited Company Overview

Table 188    Aspen Pharmacare Holdings Limited Financial Overview

Table 189    Taj Pharmaceuticals Ltd. Company Overview

Table 190    Taj Pharmaceuticals Ltd. Financial Overview

Table 191    Other Prominent Players Company Overview

Table 192    Other Prominent Players Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: The online pharmacies segment is expected to hold the highest market share in the Global Adrenocorticotropic Hormone Market by distribution channel.
Ans: The rheumatology segment is expected to hold the highest market share in the Global Adrenocorticotropic Hormone Market by indication.
Ans: Major factors driving the growth of Global Adrenocorticotropic Hormone Market include increasing prevalence of disorders related to the adrenal gland and rising geriatric population worldwide.
Ans: In 2022, the Global Adrenocorticotropic Hormone Market size was estimated at USD 1.39 billion.
Ans: Key players in Global Adrenocorticotropic Hormone Market include Novartis International AG, Pfizer Inc., Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals PLC, West-Ward Pharmaceuticals Corp., Horizon Therapeutics plc, Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Ferring Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Amphastar Pharmaceuticals, Inc., EMD Serono, Inc., Mylan N.V., and Taj Pharmaceuticals Ltd. 
array(1) {
  ["__ci_last_regenerate"]=>
  int(1734954882)
}